Impact of biochemical failure on long-term clinical outcome after radical prostatectomy for prostate cancer in Japan

被引:0
作者
S Egawa
Y Matsui
K Matsumoto
K Suyama
Y Arai
S Kuwao
S Baba
机构
[1] Kitasato University School of Medicine,Department of Urology
[2] Kitasato University School of Medicine,Department of Pathology
[3] Kurashiki Central Hospital,Department of Urology
来源
Prostate Cancer and Prostatic Diseases | 2004年 / 7卷
关键词
radical prostatectomy; prostate-specific antigen; biochemical failure; overall survival;
D O I
暂无
中图分类号
学科分类号
摘要
Detailed information is needed to understand the impact of biochemical failure (bF) on long-term outcome after definitive therapy for prostate cancer. In all, 223 consecutive men treated with radical retropubic prostatectomy were followed and long-term clinical outcome was investigated. Pathological examination revealed more locally advanced tumors in this study compared with the typical cohorts seen in the Western series. The Cox proportional hazards model indicates pretreatment prostate-specific antigen levels and risk group stratification to be a significant predictors for bF (P<0.05), but not for overall survival. Seminal vesicle involvement was a significant predictor of systemic progression, cancer death and overall survival (P<0.05). Positive surgical margin and bF were also found to be independent predictors of overall survival (P<0.05). In contrast to reports from Western countries, this study found a significant correlation between bF after radical prostatectomy and overall survival. This may reflect years-later detection of prostate cancer in Japan compared with Western series. Biochemical failure may ultimately be translated into decreased overall survival after sufficient follow-up.
引用
收藏
页码:152 / 157
页数:5
相关论文
共 20 条
[1]  
Pound CR(1999)Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1591-1597
[2]  
Jhaveri FM(1999)Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results Urology 54 884-890
[3]  
Zippe CD(2002)Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era Int J Radial Oncol Biol Phys 52 704-711
[4]  
Klein EA(2003)Pretreatment predictors of time to cancer specific death after prostate specific antigen failure J Urol 169 1320-1324
[5]  
Kupelian PA(1993)Clinical evaluation of a new kit (IMx PA Dainapack) for detection of serum prostate specific antigen Acta Urol Japon 39 977-984
[6]  
Kupelian PA(2000)Infrequent involvement of the anterior base in low-risk patients with clinically localized prostate cancer and its possible significance in definitive radiation therapy Jpn J Clin Oncol 30 126-130
[7]  
D'Amico AV(2001)Detection of prostate cancer by prostate-specific antigen Biomed Pharmacother 55 130-134
[8]  
Machida T(1997)Impact of life expectancy and tumor doubling time on the clinical significance of prostate cancer in Japan Jpn J Clin Oncol 27 394-400
[9]  
Egawa S(1994)The clinical usefulness of prostate specific antigen: update 1994 J Urol 15 1358-1368
[10]  
Egawa S(1994)Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer J Urol 152 1850-1857